An interventional study of Trak Telerehabilitation Platform and Conventional Rehabilitation Program in Shoulder Pain, sponsored by Trak Health Solutions S.L.. Recruiting at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-04-08.
Sponsored by Trak Health Solutions S.L. · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 52 studies in Shoulder Pain with a site in Spain — 10 open to participants now, 10 under way, none of them phase 3. Shoulder Pain · Spain.
Among the 52 studies in Shoulder Pain with a site in Spain, this one is the 3rd largest by planned enrollment of the 49 interventional ones that give a count, is one of 8 that started in 2024, is one of 47 with no phase, and was the 42nd registered.
738 studies on the registry are indexed under Shoulder Pain; 168 are open to participants now.
Browse Shoulder Pain studies →10 of the 52 studies in Shoulder Pain with a site in Spain are open now. Recruiting first, the newest first:
University of Alcala · Sites in Spain
Ages 18–80
University of Alcala · Sites in Spain
Ages 18–70 · Healthy volunteers
University of Seville · Sites in Spain
Ages 18+
University of Salamanca · Sites in Spain
Ages 18–55
Universidad Complutense de Madrid · Sites in Spain
Ages 18+
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 90 Shoulder Pain studies recruiting now, 25 (28%) set no upper age limit and 55 (61%) stop at 75 or younger; 3 take children under 18; 15 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
52 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 8 started in 2024.
This study's planned enrollment of 95 is above the median of 60 across 590 interventional studies indexed under Shoulder Pain.
Median enrollment 50 across the 49 interventional studies, 159 across the 3 observational. Of the 34 that completed or were terminated, 1 (3%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 52 have an industry lead sponsor. The 10 most frequent:
Trak Health Solutions S.L. is the lead sponsor of 6 studies on the registry; 2 are open to participants now.
Trak Health Solutions S.L. has 1 study filed under Shoulder Pain — fewer than ten, so there is no comparison to draw.
4 of the studies in Shoulder Pain with a site in Spain that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06296979University of SevilleEffectiveness of Noninvasive Phrenic Nerve Neuromodulation in Shoulder Pain and Hepatobiliary Visceral Comorbidity. | 2026-12-01 |
| NCT06398574University of AlcalaEffects of Dry Needling on the Behavior of the Shoulder Muscles | 2026-12-20 |
| NCT07637760Universidad Complutense de MadridDry Needling or Percutaneous Electrolysis for Managing Myofascial Trigger Points? | 2027-01-30 |
| NCT07621016Universidad Europea de ValenciaEffects of Dry Needling in Athletes With Subacromial Pain Syndrome | 2027-03 |
Add all 4 to your calendar (.ics) → With an account.
Among the 52 studies in Shoulder Pain with a site in Spain, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This clinical trial aims to analyze the usability and degree of satisfaction of two populations, healthcare personnel (Population 1) in rural areas and their patients (Population 2), with the TRAK tele-rehabilitation tool.
Participants will undergo telerehabilitation treatment through the TRAK platform for eight weeks (treatment group) or follow an at home exercise protocol (control group).
The recruitment process for this study is aimed at patients with shoulder pain (population 2) and healthcare personnel (population 1).
After the initial screening, individuals who meet the study's predefined inclusion criteria will be invited to participate. Before enrollment, written informed consent will be obtained from all participants, ensuring ethical compliance and respect for individual autonomy.
The healthcare personnel (population 1) will use Trak during the entire study period, from the time of entry into the study to the time of exit.
The study cohort will consist of patients randomly assigned to the experimental group (EG) and the control group (CG) on the first in person visit for the population 2 (patients). Regardless of group assignment, all patients will undergo baseline health assessments, ensuring that their individual needs are met. The satisfaction questionnaire will be deferred until post-intervention for both groups.
Participants in both groups will begin by filling out the Quality of Life Scale (EuroQol 5). and Shoulder Functional Assessment Scale (SPADI-Br) on the first visit.
In the case of the treatment group (EG), the participants will use the platform following the treatment prescribed by their health professionals for a period of 2 months. in the case of the control group (CG), the patients will follow the usual clinical practice treatment (they will receive the exercise protocol in paper format).
At the end of the treatment period, a final face-to-face visit will be made.
Patients (population 2) will undergo 8 weeks of treatment through the TRAK tool (https://www.trakphysio.com/es/) in the EG. Patients from the EG will carry out the treatment through the platform at home, and those from the CG will follow an on paper exercise protocol based on the usual (in-person) clinical practice methodology. Both groups will perform exercises in these rehabilitation sessions to improve shoulder mobility.
The results will be evaluated using different métrics, such as Telemedicine Usability Questionnaire (TUQ) and Telemedicine Satisfaction and Usefulness Questionnaire (TSUQ), wich are the main ones, number of patients using the platform, the EuroQol-5D and the shoulder functional evaluation scale (SPADI-Br). These scales will be completed on paper at the beginning and end of the study for both groups.
Inclusion Criteria population 1:
Exclusion Criteria population 1:
Inclusion Criteria population 2:
Exclusion Criteria population 2:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients will use Trak platform for 8 weeks (2 months) for their exercise program. The use of the tool involves performing the corresponding therapeutic exercise program through it. The frequency of the exercises will be determined by the healthcare professional responsible for the patient, based on the needs identified during the assessment, ranging from 3 to 7 days per week.
Other: Trak Telerehabilitation Platform
Patients in the control group will undergo the same rehabilitation period (8 weeks) but following standard clinical practice.
Other: Conventional Rehabilitation Program
Healthcare professionals who will have access to the tool to prescribe exercise sessions for their patients, monitor their progress, adapt and modify the exercise program, communicate with patients to address their questions, and track their progress over time.
Other: Trak Telerehabilitation Platform
The exercise protocol designed is carried out through TRAK, the digital rehabilitation tool.
Exercise protocol with the methodology of conventional clinical practice.
Telemedicine Usability Questionnaire (TUQ).
The TUQ is a questionnaire specifically designed to measure (from 17 to 109 points) the usability of telemedicine systems from the perspective of healthcare personnel.
Time frame: Last visit, week 8
Telemedicine Satisfaction and Usefulness Questionnaire (TSUQ).
Scale designed to evaluate the satisfaction and usefulness perceived by telemedicine users from 17 to 85 points.
Time frame: Last visit, week 8
European quality of life 5 dimension questionnaire (EuroQol-5D)
Generic and standardized questionnaire developed to describe and assess health-related quality of life. This questionnaire has an EVA scale from 0 to 100 and 5 questions that gives a 5 digit patient profile (From 11111 if the patients does not have problems on any item to 33333 if the patients have severe problems). The items valued are personal care, daily activities, mobility, pain and anxiety/depression.
Time frame: week 1 and 8
Focus on Shoulder Pain and Disability Index (SPADI-Br).
The SPADI-Br was designed to evaluate the degree of shoulder pain and discomfort in performing activities of daily living from 0 to 130 points.
Time frame: week 1 and 8
Number of patients using the platform
The total number of patients who are using the TRAK platform.
Time frame: week 8
Started Feb 2024 (actual). Primary completion is estimated for May 2025, 14 months after the start.
Of 356 interventional studies with no phase under Shoulder Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 27. This study's planned 14 months is above that.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Trak Health Solutions S.L.